112 related articles for article (PubMed ID: 20571282)
1. Mediterranean weather conditions and exacerbations of multiple sclerosis.
Saaroni H; Sigal A; Lejbkowicz I; Miller A
Neuroepidemiology; 2010 Aug; 35(2):142-51. PubMed ID: 20571282
[TBL] [Abstract][Full Text] [Related]
2. Influence of climatic factors in the incidence of multiple sclerosis relapses in a Portuguese population.
Fonseca AC; Costa J; Cordeiro C; Geraldes R; de Sá J
Eur J Neurol; 2009 Apr; 16(4):537-9. PubMed ID: 19187257
[TBL] [Abstract][Full Text] [Related]
3. Temporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence.
Oikonen M; Laaksonen M; Aalto V; Ilonen J; Salonen R; Erälinna JP; Panelius M; Salmi A
Mult Scler; 2011 Jun; 17(6):672-80. PubMed ID: 21212088
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis: relapses and timing of remissions.
Iuliano G; Napoletano R; Esposito A
Eur Neurol; 2008; 59(1-2):44-8. PubMed ID: 17917457
[TBL] [Abstract][Full Text] [Related]
5. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis.
Tremlett H; van der Mei IA; Pittas F; Blizzard L; Paley G; Mesaros D; Woodbaker R; Nunez M; Dwyer T; Taylor BV; Ponsonby AL
Neuroepidemiology; 2008; 31(4):271-9. PubMed ID: 18971584
[TBL] [Abstract][Full Text] [Related]
6. The month of birth and the incidence of multiple sclerosis in the Israeli population.
Givon U; Zeilig G; Dolev M; Achiron A
Neuroepidemiology; 2012; 38(1):64-8. PubMed ID: 22237026
[TBL] [Abstract][Full Text] [Related]
7. Disease relapses in multiple sclerosis can be influenced by air pollution and climate seasonal conditions.
Vojinović S; Savić D; Lukić S; Savić L; Vojinović J
Vojnosanit Pregl; 2015 Jan; 72(1):44-9. PubMed ID: 26043590
[TBL] [Abstract][Full Text] [Related]
8. Relapses and progression of disability in multiple sclerosis.
Confavreux C; Vukusic S; Moreau T; Adeleine P
N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
[TBL] [Abstract][Full Text] [Related]
9. Seasonal variations in exacerbations and MRI parameters in relapsing-remitting multiple sclerosis.
Koziol JA; Feng AC
Neuroepidemiology; 2004; 23(5):217-23. PubMed ID: 15316247
[TBL] [Abstract][Full Text] [Related]
10. Limited impact of the summer heat wave in France (2003) on hospital admissions and relapses for multiple sclerosis.
Tataru N; Vidal C; Decavel P; Berger E; Rumbach L
Neuroepidemiology; 2006; 27(1):28-32. PubMed ID: 16804331
[TBL] [Abstract][Full Text] [Related]
11. Short-term relationship between meteorological variables and hip fractures: an analysis carried out in a health area of the Autonomous Region of Valencia, Spain (1996-2005).
Tenías JM; Estarlich M; Fuentes-Leonarte V; Iñiguez C; Ballester F
Bone; 2009 Oct; 45(4):794-8. PubMed ID: 19563926
[TBL] [Abstract][Full Text] [Related]
12. Predictors of relapse rate in MS clinical trials.
Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
[TBL] [Abstract][Full Text] [Related]
13. Seasonal patterns of relapse and disability in Danish MS patients: A population-based cohort study.
Elser HC; Koch-Henriksen N; Magyari M
Mult Scler Relat Disord; 2021 Apr; 49():102739. PubMed ID: 33450501
[TBL] [Abstract][Full Text] [Related]
14. Monthly variation of multiple sclerosis activity in the southern hemisphere: analysis from 996 relapses in Brazil.
Damasceno A; Von Glehn F; de Deus-Silva L; Damasceno BP
Eur J Neurol; 2012 Apr; 19(4):660-2. PubMed ID: 21972914
[TBL] [Abstract][Full Text] [Related]
15. Early relapses, onset of progression, and late outcome in multiple sclerosis.
Scalfari A; Neuhaus A; Daumer M; Deluca GC; Muraro PA; Ebers GC
JAMA Neurol; 2013 Feb; 70(2):214-22. PubMed ID: 23407713
[TBL] [Abstract][Full Text] [Related]
16. Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis.
Prosperini L; Giannì C; Barletta V; Mancinelli C; Fubelli F; Borriello G; Pozzilli C
J Neurol Sci; 2012 Dec; 323(1-2):104-12. PubMed ID: 23006974
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis relapses: a multivariable analysis of residual disability determinants.
Vercellino M; Romagnolo A; Mattioda A; Masera S; Piacentino C; Merola A; Chiò A; Mutani R; Cavalla P
Acta Neurol Scand; 2009 Feb; 119(2):126-30. PubMed ID: 18684216
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of initial relapses on the evolution of disability in patients with relapsing-remitting multiple sclerosis.
Binquet C; Quantin C; Le Teuff G; Pagliano JF; Abrahamowicz M; Moreau T
Neuroepidemiology; 2006; 27(1):45-54. PubMed ID: 16825794
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study.
Leone MA; Bonissoni S; Collimedaglia L; Tesser F; Calzoni S; Stecco A; Naldi P; Monaco F
Mult Scler; 2008 May; 14(4):485-93. PubMed ID: 18208889
[TBL] [Abstract][Full Text] [Related]
20. Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience.
Pozzilli C; Prosperini L; Sbardella E; De Giglio L; Onesti E; Tomassini V
Neurol Sci; 2005 Dec; 26 Suppl 4():S174-8. PubMed ID: 16388353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
